What Diamondback Drugs does

Diamondback Drugs operates as a veterinary compounding pharmacy serving the full spectrum of animal healthcare — companion pet owners, equine veterinarians and horse owners, zoos, aquariums, wildlife rehabilitators, deer ranchers, and research institutions. The company custom-formulates pharmaceuticals that are commercially unavailable, difficult to administer, or require species-specific dosing, offering delivery formats including transdermal gels, tiny tabs, ophthalmic suspensions, and flavored suspensions (e.g., peppermint, alfalfa, cherry). Its 46,000+ medication formulary and FDA-registered 503B outsourcing facility status differentiate it from traditional 503A compounders on quality and regulatory profile, supplemented by PCAB, LegitScript, and BBB certifications.

The technology layer centers on Blue Rabbit, a PIMS-integrated e-prescribing platform that connects veterinary practices to the company's formulary and supports prescription management, ordering, and home delivery for pet owners. Blue Rabbit functions as both a workflow tool for veterinary clinics and a direct-to-consumer channel, and is intended to make the pharmacy a single-vendor purchasing experience for both custom compounds and commercial medications, diets, and supplements. Distribution is omnichannel: direct B2B ordering with veterinary practices, DTC online pharmacy (wedgewood.pet), Blue Rabbit Home Delivery, and specialty channels for wildlife and equine segments.

Revenue is generated primarily through per-prescription sales of compounded medications at quote-based pricing, supplemented by subscription access to the Blue Rabbit platform for veterinary practices. The business shows active 2024 strategic activity — integration of Precision Equine Pharmacy (equine vertical build-out), launch of compounded molnupiravir for feline FIP, the Blue Rabbit platform introduction, and a CEO transition — alongside an Inc. Power Partner award in 2023. Note: the firmographic record lists Diamondback Drugs at 51–100 employees, while the operational data (40+ year compounding history, 503B facility, multi-vertical formulary, platform) is consistent with substantially larger scale; this discrepancy should be reconciled during diligence.

Name

Diamondback Drugs

Website

https://diamondbackdrugs.com

Company type

Private

Founded year

2001

Headcount range

51–100 employees

Short description

Diamondback Drugs operates a veterinary compounding pharmacy with a 46,000+ medication formulary, an FDA-registered 503B outsourcing facility, and the Blue Rabbit PIMS-integrated e-prescribing and home-delivery platform, serving companion animal and equine practices, pet owners, zoos, and research institutions.

Ownership category

akta.pro rank

Product category

Veterinary Pharmacy / Animal Pharmaceutical Compounding

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Compounding Pharmacies (Veterinary) (HLAMAIAD)

akta.pro secondary industries

Veterinary Inventory, Pharmacy & Medication Management (HLAMAMAF), E‑prescribing, Pharmacy Ordering & Medication Management (Rx, Refills, Home Delivery Integrations) (HLAMAGAF)

Keywords

• Veterinary compounding pharmacy
• Compounded pet medications
• 503B outsourcing facility
• PIMS-integrated e-prescribing
• Animal drug compounding

Headquarters

HQ city

Scottsdale

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Compounded Veterinary Medications: Sale of customized pharmaceutical preparations for animals including companion pets, equine, and wildlife. Revenue generated through prescription orders from veterinary practices and pet owners, utilizing a 503B outsourcing facility for compliant compounding.
2. Blue Rabbit Platform Services: Subscription-based access to PIMS-integrated e-prescribing platform enabling veterinary practices to manage prescriptions, order medications, and provide home delivery services to pet owners.

Pricing tiers

Distribution channels3 records

Marketing channels7 records

Core offering

Diamondback Drugs (operating alongside Wedgewood Pharmacy) provides custom-compounded veterinary medications across companion animal, equine, and wildlife/exotic segments, sold on a per-prescription basis through the Blue Rabbit PIMS-integrated e-prescribing platform and direct-to-consumer online pharmacy. The company operates an FDA-registered 503B Outsourcing Facility for higher-quality compounded preparations and supports veterinary practices with home delivery for pet and horse owners. A formulary of 46,000+ veterinary medications spans transdermal gels, tiny tabs, ophthalmic suspensions/solutions, and flavored suspensions (including peppermint and alfalfa equine flavors).

Product overview

Wedgewood (associated with Diamondback Drugs) operates as a veterinary pharmacy offering compounded pet medications through a platform-plus-modules architecture. The core offering includes veterinary compounding services and a 503B outsourcing facility, supported by the Blue Rabbit PIMS-integrated platform for e-prescribing and practice management. Additional modules include Blue Rabbit Home Delivery for pet owners and specialized equine pharmacy services (formerly Precision Equine Pharmacy). The formulary includes approximately 46,000 veterinary medications across various dosage forms.

Differentiator

Problem solved

Functional benefit

Products and services

• Veterinary Compounding Services Custom-compounded medications for companion animals (dogs, cats, avian), equine patients, and wildlife/exotic species across formats including transdermal gels, tiny tabs, ophthalmic suspensions/solutions, and flavored suspensions (e.g., peppermint, alfalfa). Available per veterinary prescription through the Blue Rabbit platform and direct-to-consumer online pharmacy.
• Blue Rabbit PIMS-integrated platform enabling veterinarians to prescribe custom compounds and commercial medications, diets, and supplements in one place. Includes e-prescribing, practice management integration, prescription management, and home delivery capabilities for pet and horse owners.
• 503B Outsourcing Facility FDA-registered 503B outsourcing facility providing compounded veterinary medications under heightened cGMP quality and regulatory standards, supplying veterinary practices and hospitals with compliant preparations.
• Equine Pharmacy Services (Precision Equine Pharmacy) Specialized equine pharmacy services offering horse-specific compounded medications and formulations including performance, pain management, and transdermal gel preparations with flavor options such as peppermint and alfalfa.
• Blue Rabbit Home Delivery Direct-to-door prescription delivery service for pet and horse owners receiving compounded medications ordered through the Blue Rabbit platform or the Wedgewood Pet online pharmacy.
• Compounded Molnupiravir for FIP Compounded molnupiravir preparation for the treatment of Feline Infectious Peritonitis (FIP) in cats, formulated through the veterinary compounding service line.

Quantifiable outcome

• 99% of veterinarians recognize Wedgewood brand
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Precision Equine PharmacycoreStrategic or Co-development PartnerPrecision Equine Pharmacy completed integration with Wedgewood in July 2024, combining specialized equine compounding expertise under the Wedgewood brand. This merger expanded Wedgewood's equine pharmacy capabilities and product offerings for horse owners and equine veterinarians.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Wedgewood Pharmacy: The dominant North American veterinary compounding pharmacy; appears to be the same or sister operation to Diamondback Drugs based on the URL redirect pattern (diamondbackdrugs as a UTM source for wedgewood.com). Operates the Blue Rabbit PIMS-integrated platform, 503B Outsourcing Facility, and 46,000+ medication formulary referenced in the source data.
• Vetsource: A leading veterinary pharmacy and home delivery platform serving practices nationwide with e-prescribing and prescription management workflow. Direct overlap with the Blue Rabbit offering on B2B e-prescribing and home delivery modules serving the same veterinary practice customer.

Emerging players

• Stokes Pharmacy: A 503B-registered compounding pharmacy serving human and veterinary patients with custom preparations and outsourcing capabilities. Comparable as a direct 503B/compounding competitor with regulatory parity and overlapping preparation modalities to those used in veterinary medicine.
• Vetcove: A veterinary supply marketplace and procurement platform that aggregates ordering for independent practices. Comparable as a digital practice procurement layer and could be a substitute (or channel) for the Blue Rabbit ordering workflow at the practice level.
• Fagron: Global leader in pharmaceutical compounding raw materials, semisolids, and equipment, with veterinary compounding as a meaningful growth line. Comparable as a competing compounding supply chain participant with veterinary segment exposure and shared regulatory backdrop (USP, GFI #256).
• Medisca: A pharmaceutical compounding supplier providing active ingredients, bases, and equipment to compounding pharmacies (human and veterinary). Comparable as an upstream compounding supplier with overlap in veterinary compounding workflows, though operating further up the value chain.

Broad incumbents

• Chewy Pharmacy: Direct-to-consumer pet pharmacy and supplies retailer with a national prescription fulfillment footprint. Comparable as a competing D2C channel for compounded and commercial veterinary medications targeting pet owners — represents consumer-side competition to Wedgewood Pet Online Pharmacy.
• Patterson Veterinary: A major distributor of veterinary supplies, equipment, and pharmacy products to companion-animal practices across the US. Comparable as a broad-line supplier serving the same veterinary practice buyer with pharmacy, consumables, and equipment under one commercial relationship.
• 1-800-PetMeds (PetMeds): A long-established direct-to-consumer pet pharmacy retailer offering prescription and OTC medications with home delivery. Comparable as a competitor in the consumer-side channel and as a reference for scaled D2C pet pharmacy economics.
• MWI Animal Health (Covetrus): One of the largest US veterinary distributors and pharmacy services platforms, offering practice owners ordering, pharmacy, and inventory management at scale. Overlaps with Diamondback/Wedgewood's B2B practice channel and represents the incumbent distribution and pharmacy platform alternative to Blue Rabbit.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/diamondbackdrug
• Facebookfacebook.com/diamondbackdrugs
• LinkedInlinkedin.com/company/diamondback-drugs

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diamondback Drugs